Investor Update
Basel, 5th October 2007
Roche’s
Investor and Analyst Briefing on our Hepatitis Franchise at AASLD
Monday, 5th November,
2007
We are pleased to invite you to Roche’s Analyst Briefing at the
Annual Meeting of the American Association for the Study of the Liver Diseases (AASLD) in Boston. At
this event we will provide an up-date of Roche’s strategy in Hepatitis, our current products performance,
along with an overview of our clinical trial program and promising pipeline candidates.
Following
the briefing we would like to invite you to join us for a light dinner and informal discussion on our
Hepatitis franchise and our overall business.
| Event Date: | Monday, 5th November, 2007 |
| Briefing commences: | 18:30 - 20:00 EDT (Boston) |
| 00:30 - 02:00 CET (Zurich) | |
| 23:30 - 01:00 GMT (London) | |
| Apéro and Dinner: | 20:00 EDT |
| Location: | Hotel Westin Copley Place Boston |
| Meeting Room “Great Republic, 7th floor” | |
| 10 Huntington Avenue, Boston |
Concurrent
conference call: Dial in to the conference
10-15 min prior to the scheduled start using the following numbers:
- +41 (0) 91 610 56 00 (Europe and ROW)
- +1 (1) 866 291 41 66 (USA Toll Free)
- +44 (0) 207 107 06 11 (UK)
Presentation
slides will be posted on the
Roche IR website ir.roche.com.
Alternatively a live
audio webcast can be accessed
via ir.roche.com.
A replay of the conference
call will be available
one hour after the conference call, for 48 hours. Access by dialing:
- +41 91 612 43 30 (Europe and ROW) or
- +44 207 108 62 33 (UK)
- +1 (1) 866 416 25 58 (USA)
- Enter the ID 338 followed by the # sign.
A
replay
of the webcast will be available on demand at ir.roche.com.
Dowload
registration Form